UNIGE document Scientific Article
previous document  unige:89616  next document
add to browser collection

Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation

Chaigne, Benjamin
Geneugelijk, Kirsten
Ahmed, Mohamed Alibashe
Hönger, Gideon
Demuylder-Mischler, Sandrine
show hidden authors show all authors [1 - 11]
Published in Cell transplantation. 2016, vol. 25, p. 2041-2050
Abstract The aim of the current study was to characterize the anti-HLA antibodies before and after pancreatic islet or pancreas transplantation. We assessed the risk of anti-donor specific antibody (DSA) sensitization in a single-center, retrospective clinical study at Geneva University Hospital. Data regarding clinical characteristics, graft outcome, HLA mismatch, donor HLA immunogenicity and anti-HLA antibody characteristic were collected. Between January 2008 and July 2014, 18 patients received islet transplants and 26 patients received a pancreas transplant. Eleven out of 18 patients (61.1%) in the islet group and 12 out of 26 patients (46.2%) in the pancreas group had anti-HLA antibodies. Six patients (33.3%) developed DSA against HLA of the islets and 10 patients (38.4%) developed DSA against HLA of the pancreas. Most of the DSA were at low level. Several parameters such as gender, number of transplantation, HLA mismatch, eplet mismatch and PIRCHE-II numbers, rejection and infection were analyzed. Only the number of PIRCHE-II was associated with the development of anti-HLA class II de novo DSA. Overall, the development of de novo DSA did not influence graft survival as estimated by insulin independence. Our results indicated that pre-transplant DSA at low levels, do not restrict islet or pancreas transplantation, especially islets transplantation (27.8% versus 15.4.%). de novo DSA do occur at a similar rate in both pancreas and islet transplant recipients mainly of class II and the immunogenicity of donor HLA is a parameter that should be taken into consideration. Low level DSA combined with an adequate immunosuppressive regimen and a close follow-up is acceptable in both pancreas and islet transplantation and are not associated with reduced graft survival or graft function.
PMID: 27196533
Full text
Article (Published version) (438 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Insuffisance rénale chronique (941)
La transplantation d'îlots de Langerhans (623)
Transplantation immunologie et osteoimmunologie (561)
(ISO format)
CHAIGNE, Benjamin et al. Immunogenicity of anti-HLA antibodies in pancreas and islet transplantation. In: Cell transplantation, 2016, vol. 25, p. 2041-2050. doi: 10.3727/096368916X691673 https://archive-ouverte.unige.ch/unige:89616

442 hits



Deposited on : 2016-11-30

Export document
Format :
Citation style :